Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

NUP98-HOXA9 -Initiates Molecular and Biologic Features of Disease Progression in a Humanized Model of CML

Ivan Sloma, PharmD, PhD, Philip Beer, PhD FRCPath, MRCP, Christophe Desterke, PhD, Elizabeth Bulaeva, Misha Bilenky, Michelle Moksa, Kamini Raghuram, Cedric Brimacombe, Karen Lambie, Ali G Turhan, MD PhD, Orianne Wagner-Ballon, MD PhD, Philippe Gaulard, MD PhD, R. Keith Humphries, MD PhD, Martin Hirst, PhD BS, Connie J. Eaves, PhD

Blood (2019) 134 (Supplement_1): 4139.

https://doi.org/10.1182/blood-2019-127839

Published: 2019

Journal Articles

The Absolute Count of Circulating, Classical, CD14 ++ /CD16 - Monocytes Is a Poor Prognosis Marker in Chronic Myelomonocytic Leukemia (CMML)

Matthieu Jestin, Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Ivan Sloma, PharmD,PhD, Margot Morabito, Sébastien Maury, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD

Blood (2019) 134 (Supplement_1): 4242.

https://doi.org/10.1182/blood-2019-121794

Published: 2019

Journal Articles

Persistence of PNH Clones over Time: Insights from the Mid-Term Analysis of the French Nation-Wide Multicenter Prospective Observational Study

Magali Le Garff-Tavernier, Agathe Pruvot Debliquis, PharmD, Thomas Boyer, MD, Jean-Philippe Vial, MD, Véronique Harrivel, MD, Anne-Catherine Lhoumeau, PhD PharmD, Marie-Christine Jacob, MD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD, Bernard Drenou, MD PhD, Orianne Wagner Ballon, MD PhD

Blood (2019) 134 (Supplement_1): 1218.

https://doi.org/10.1182/blood-2019-123415

Published: 2019

Journal Articles

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Margot Morabito, Jeffie Lafosse, Andrea Toma, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD

Blood (2018) 132 (Supplement 1): 4376.

https://doi.org/10.1182/blood-2018-99-116451

Published: 2018

Journal Articles

Iron Deficiency Anemia, a Rare and Potentially Underestimated Cause of Thrombocytopenia and a Differential Diagnosis of Immune Thrombocytopenia (ITP): Results from a Retrospective Case-Controlled Study

Tessa Huscenot, Darnige Luc, MD, Orianne Wagner Ballon, MD PhD, Loustau Valentine, MD, Delphine Gobert, MD, Marie Le cann, MD, Caroline Morbieu, MD, Marc Michel

Blood (2018) 132 (Supplement 1): 4984.

https://doi.org/10.1182/blood-2018-99-118532

Published: 2018

Journal Articles

Red Blood Cell Lysis Procedure Improves the Performances of ELN Dyserythropoiesis Score Compared to Nuclear Dye Use without Lysis

Hugo Germain, Sihem Tarfi, PharmD, Nicolas Freynet, PharmD, Andrea Toma, MD PhD, Bouchra Badaoui, PharmD, Orianne Wagner Ballon, MD PhD

Blood (2018) 132 (Supplement 1): 3108.

https://doi.org/10.1182/blood-2018-99-114179

Published: 2018

Journal Articles

Increased Myelofibrosis in Thrombospondin-1-Null Mice Is Associated with Enhanced TGF-β1-Mediated Response by Bone Marrow Fibroblasts

Solène Evrard, Micheline Tulliez, MD, Eva Zetterberg, MD, PhD, Jan Palmblad, MD, PhD, William Vainchenker, MD, PhD, Jean-Luc Villeval, PhD, Stéphane Giraudier, MD, PhD, Orianne Wagner-Ballon, MD, PhD

Blood (2008) 112 (11): 2796.

https://doi.org/10.1182/blood.V112.11.2796.2796

Published: 2008

Journal Articles

Evidence That the MPL 515L and 515K Mutations Occur in a Lympho-Myeloid Progenitor in Idiopathic Myelofibrosis and Are Associated with TPO Hypersensitivity.

Ronan Chaligne, Jean-Pierre Le Couedic, sRA, Carole Tonetti, sRA, Rodolphe Besancenot, MD, Orianne Wagner-Ballon, MD, PhD, Najet Debili, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD

Blood (2006) 108 (11): 117.

https://doi.org/10.1182/blood.V108.11.117.117

Published: 2006

Journal Articles

Proteasome Inhibitor Bortezomib Can Inhibit Bone Marrow Fibrosis Development in a Murine Model of Myelofibrosis.

Orianne Wagner-Ballon, MD, Thomas Gastinne, MD, Micheline Tulliez, MD, Catherine Lacout, Didier Pisani, PhD, Hedia Chagraoui, PhD, Jean-Luc Villeval, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD

Blood (2005) 106 (11): 2582.

https://doi.org/10.1182/blood.V106.11.2582.2582

Published: 2005

Journal Articles

Adenoviral Mediated TGF-β1inhibition in a Murine Model of Myelofibrosis Can Prevent and Cure Bone Marrow Fibrosis Development.

Thomas Gastinne, MD, Orianne Wagner-Ballon, MD, Micheline Tulliez, MD, Hedia Chagraoui, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD

Blood (2004) 104 (11): 794.

https://doi.org/10.1182/blood.V104.11.794.794

Published: 2004

NARROW

NUP98-HOXA9 -Initiates Molecular and Biologic Features of Disease Progression in a Humanized Model of CML

The Absolute Count of Circulating, Classical, CD14 ++ /CD16 - Monocytes Is a Poor Prognosis Marker in Chronic Myelomonocytic Leukemia (CMML)

Persistence of PNH Clones over Time: Insights from the Mid-Term Analysis of the French Nation-Wide Multicenter Prospective Observational Study

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Iron Deficiency Anemia, a Rare and Potentially Underestimated Cause of Thrombocytopenia and a Differential Diagnosis of Immune Thrombocytopenia (ITP): Results from a Retrospective Case-Controlled Study

Red Blood Cell Lysis Procedure Improves the Performances of ELN Dyserythropoiesis Score Compared to Nuclear Dye Use without Lysis

Increased Myelofibrosis in Thrombospondin-1-Null Mice Is Associated with Enhanced TGF-β1-Mediated Response by Bone Marrow Fibroblasts

Evidence That the MPL 515L and 515K Mutations Occur in a Lympho-Myeloid Progenitor in Idiopathic Myelofibrosis and Are Associated with TPO Hypersensitivity.

Proteasome Inhibitor Bortezomib Can Inhibit Bone Marrow Fibrosis Development in a Murine Model of Myelofibrosis.

Adenoviral Mediated TGF-β1inhibition in a Murine Model of Myelofibrosis Can Prevent and Cure Bone Marrow Fibrosis Development.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only